Stark resultatutveckling i Q2'22 BE Group levererade ett underliggande rörelseresultat på 291 mkr i ...
Redeye retains its positive view on Proact following a solid Q2 report where strong System sales pos...
Redeye comments on the news that Careium’s CEO Carl-Johan Zetterberg Boudrie is set to leave his pos...
Organiska tillväxten accelererade från Q2 Elanders rapporterade organisk tillväxt på 4% (2% i Q1'22)...
Negativ organisk tillväxt då bolaget ökar fokus på vinsten.
This morning, Adverty, in collaboration with SeenThis launched the industry’s first streaming techno...
Q2 report due Tuesday, 23 August We expect 167% adj.
Q2 report due on Wednesday, 20 July Adj. EBITA lowered by 5-3% for ’22e-’24e Trading at 14-11x ’22e-...
Q2: 4% sales beat due to 8% better device sales Likely core markets that are performing well New mar...
Redeye maintains its positive view and reiterates our Base Case of SEK 42 per share.
The Thoracic recovery continues, and the organic growth in constant currencies is a robust 24% compa...
Q2: EBITDA excl ALS ~NOK 7m vs our NOK 18m Continues ramping up e-com investments Estimates likely t...
Strong margin trend continued in Q2 We increase ’22e-’24e adj.
Trianon reported a mixed set of numbers for Q2. On the negative side, IFPM fell 10% short of our est...
Elanders presented a strong Q2 report, with 11% organic growth for Supply Chain Solutions, driven by...
Cibus will report its Q2 results on 21 July. We expect net operating income (NOI) of EUR 25.
Coor visade en stark rapport efter Q1. För detta kvartal förväntas lönsamheten sjunka något och till...
Redeye är fortsatt positiva till BioArctic efter att ha tagit del av företagets Q2-rapport, som inte...
Mackmyras omsättning i årets första kvartal var den näst högsta någonsin.
Net operating income -7% vs ABGSCe IFPM in the earnings capacity up by 6% Occupancy rate up 0.
